Home › Neuroendocrine Tumors › Nebraska › Omaha
Neuroendocrine Tumors clinical trials in Omaha, NE
5 studies for Neuroendocrine Tumors are looking for participants at sites in and around Omaha (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecruitingPhase 2/3
- University of Nebraska Medical Center, Omaha
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
RecruitingPhase 1/2
- Nebraska Cancer Specialists, Omaha
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Children's Hospital and Medical Center of Omaha, Omaha
- University of Nebraska Medical Center, Omaha
Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
- Methodist Estabrook Cancer Center, Omaha
- Nebraska Methodist Health System, Omaha
- University of Nebraska Medical Center, Omaha
- and 1 more
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Omaha
Neuroendocrine Tumors trials in other cities
- Washington, DC11 studies
- St. Louis, MO9 studies
- Philadelphia, PA8 studies
- Houston, TX7 studies
- Columbus, OH7 studies
- Rochester, MN7 studies
- Portland, OR6 studies
- Cleveland, OH6 studies
- Mountain View, CA6 studies
- Boston, MA6 studies
- Dallas, TX6 studies
- Los Angeles, CA6 studies
Other studies in Omaha
- Prostate Cancer29 studies
- Non-Small Cell Lung Cancer25 studies
- Breast Cancer23 studies
- Cancer (all types)19 studies
- Colorectal Cancer18 studies
- Multiple Myeloma17 studies
- Ovarian Cancer15 studies
- Pancreatic Cancer15 studies
- Head and Neck Squamous Cell Carcinoma15 studies
- Metastatic Cancer14 studies
- Non-Hodgkin Lymphoma14 studies
- Lung Cancer13 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.